6.06
price down icon3.04%   -0.19
after-market Handel nachbörslich: 6.07 0.01 +0.17%
loading

Cvrx Inc Aktie (CVRX) Neueste Nachrichten

pulisher
Apr 17, 2025

CVRx, Inc. (NASDAQ:CVRX) Shares Acquired by JPMorgan Chase & Co. - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

CVRx, Inc. (NASDAQ:CVRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

(CVRX) Investment Analysis - news.stocktradersdaily.com

Apr 15, 2025
pulisher
Apr 14, 2025

Cantor maintains CVRx stock with $20 target despite revenue miss By Investing.com - Investing.com India

Apr 14, 2025
pulisher
Apr 14, 2025

Cantor maintains CVRx stock with $20 target despite revenue miss - Investing.com

Apr 14, 2025
pulisher
Apr 12, 2025

William Blair Comments on CVRx’s Q1 Earnings (NASDAQ:CVRX) - Defense World

Apr 12, 2025
pulisher
Apr 09, 2025

CVRx's SWOT analysis: barostim maker's stock faces growth hurdles By Investing.com - Investing.com India

Apr 09, 2025
pulisher
Apr 09, 2025

CVRx stock slides on preliminary revenue miss - MSN

Apr 09, 2025
pulisher
Apr 09, 2025

CVRx, Inc.: Overreaction Creates Buying Opportunity - Seeking Alpha

Apr 09, 2025
pulisher
Apr 09, 2025

CVRx Insiders Lose Out As Stock Sinks To US$6.20 - simplywall.st

Apr 09, 2025
pulisher
Apr 09, 2025

CVRx’s SWOT analysis: barostim maker’s stock faces growth hurdles By Investing.com - Investing.com India

Apr 09, 2025
pulisher
Apr 09, 2025

CVRx's SWOT analysis: barostim maker's stock faces growth hurdles - Investing.com

Apr 09, 2025
pulisher
Apr 08, 2025

Cantor Fitzgerald maintains CVRx stock Overweight rating By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

CVRx stock touches 52-week low at $6.36 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 08, 2025

Top Midday Decliners - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

CVRx stock drops on Q1 preliminary sales number miss - MassDevice

Apr 08, 2025
pulisher
Apr 08, 2025

CVRx stock touches 52-week low at $6.36 amid market challenges - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Cantor Fitzgerald maintains CVRx stock Overweight rating - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga

Apr 08, 2025
pulisher
Apr 08, 2025

CVRx price target lowered to $14 from $19 at Lake Street - TipRanks

Apr 08, 2025
pulisher
Apr 08, 2025

Assessing CVRx: Insights From 4 Financial Analysts - Benzinga

Apr 08, 2025
pulisher
Apr 08, 2025

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Apr 08, 2025
pulisher
Apr 08, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 08, 2025
pulisher
Apr 08, 2025

Canaccord cuts CVRx stock target to $18, maintains Buy rating By Investing.com - Investing.com India

Apr 08, 2025
pulisher
Apr 08, 2025

Top Premarket Decliners - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

Canaccord cuts CVRx stock target to $18, maintains Buy rating - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

CVRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into BRONSTEIN, GEWIRTZ & GROSSMAN, LLC and Encourages Investors to Contact the Firm Today! - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

CVRx Reports Preliminary First Quarter 2025 Financial Results - The Manila Times

Apr 08, 2025
pulisher
Apr 07, 2025

CVRx (CVRX) Stock Drops as Preliminary Q1 2025 Revenue Disappoin - GuruFocus

Apr 07, 2025
pulisher
Apr 07, 2025

CVRx stock slides on preliminary revenue miss (CVRX:NASDAQ) - Seeking Alpha

Apr 07, 2025
pulisher
Apr 07, 2025

CVRx Sees Q1 Higher Revenue YOY, Missing Consensus -- Shares Fall After Hours - MarketScreener

Apr 07, 2025
pulisher
Apr 07, 2025

CVRx Posts Mixed Q1 Earnings: 15% Growth Meets Headwinds as Expansion Continues - Stock Titan

Apr 07, 2025
pulisher
Mar 30, 2025

(CVRX) Long Term Investment Analysis - news.stocktradersdaily.com

Mar 30, 2025
pulisher
Mar 29, 2025

Bank of New York Mellon Corp Increases Stake in CVRx, Inc. (NASDAQ:CVRX) - Defense World

Mar 29, 2025
pulisher
Mar 23, 2025

CVRx stock plunges 42% in wake of Q1 report, updated forecast - MSN

Mar 23, 2025
pulisher
Mar 22, 2025

CVRx, Inc. (NASDAQ:CVRX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Mar 22, 2025
pulisher
Mar 19, 2025

Several Insiders Invested In CVRx Flagging Positive News - Yahoo

Mar 19, 2025
pulisher
Mar 18, 2025

Cantor Fitzgerald maintains CVRx stock with $20 target By Investing.com - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

Cantor Fitzgerald maintains CVRx stock with $20 target - Investing.com

Mar 18, 2025
pulisher
Mar 09, 2025

(CVRX) Trading Report - Stock Traders Daily

Mar 09, 2025
pulisher
Mar 07, 2025

With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For - Simply Wall St

Mar 07, 2025
pulisher
Mar 05, 2025

Power Shift 25: Medtech firm's new CEO looks to 'build a world-class team'Minneapolis / St. Paul Business Journal - Minneapolis / St. Paul Business Journal

Mar 05, 2025
pulisher
Feb 25, 2025

CVRx, Inc. (NASDAQ:CVRX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

Analyzing Co-Diagnostics (NASDAQ:CODX) and CVRx (NASDAQ:CVRX) - Defense World

Feb 24, 2025
pulisher
Feb 19, 2025

CVRx, Inc. (NASDAQ:CVRX) Short Interest Down 9.8% in January - Defense World

Feb 19, 2025
pulisher
Feb 18, 2025

CVRx, Inc. SEC 10-K Report - TradingView

Feb 18, 2025
pulisher
Feb 17, 2025

CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles By Investing.com - Investing.com UK

Feb 17, 2025
pulisher
Feb 13, 2025

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim - GlobeNewswire

Feb 13, 2025
pulisher
Feb 12, 2025

Cvrx, Inc. Announces New Real-World Evidence Demonstrating Significant Reductions in Healthcare Utility with Barostim - Marketscreener.com

Feb 12, 2025
pulisher
Feb 12, 2025

CVRx, Inc. Presents New Real-World Evidence Demonstrating Significant Reductions in Hospital Visits After Barostim Implantation at THT Conference 2025 - Nasdaq

Feb 12, 2025
medical_devices ZBH
$96.17
price down icon 1.79%
medical_devices PHG
$23.29
price down icon 1.36%
medical_devices STE
$218.78
price down icon 1.55%
$66.11
price down icon 3.59%
$60.48
price down icon 3.03%
medical_devices EW
$69.20
price down icon 3.26%
Kapitalisierung:     |  Volumen (24h):